Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-06-07
2008-08-26
Andres, Janet L. (Department: 4131)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S232500, C514S252130, C514S337000, C549S055000, C549S057000, C549S468000
Reexamination Certificate
active
07417066
ABSTRACT:
The invention relates to compounds of general Formula I, the production thereof, and the use thereof as a medicinal product.
REFERENCES:
patent: 2006/0074084 (2006-04-01), Nguyen et al.
patent: 10 2004047272 (2006-04-01), None
patent: 2 635 776 (1990-03-01), None
patent: WO 02/20745 (2002-03-01), None
patent: WO 03/002533 (2003-01-01), None
patent: WO 03/024448 (2003-03-01), None
patent: WO 2004/041782 (2004-05-01), None
patent: WO 2005/013996 (2005-02-01), None
patent: WO 2005/034880 (2005-04-01), None
patent: WO 2005/070419 (2005-08-01), None
patent: WO 2005/092899 (2005-10-01), None
Boemer Ulf
Buchmann Bernd
Fritsch Martin
Menzenbach Bernd
Nguyen Duy
Andres Janet L.
Bianchi Kristin
Millen White Zelano & Branigan P.C.
Schering AG
LandOfFree
Inhibitors of soluble adenylate cyclase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of soluble adenylate cyclase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of soluble adenylate cyclase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4012665